Research Paper Volume 16, Issue 2 pp 1111—1127

AMIGO2 is a pivotal therapeutic target related to M2 polarization of macrophages in pancreatic ductal adenocarcinoma

class="figure-viewer-img"

Figure 8. (A) The mRNA expression of AMIGO2 in normal control SW1990 cell line and two AMIGO2 siRNA transfected SW1990 cell line; *p < 0.05, **p < 0.01, ***p < 0.001. (B) Relative proliferation tendency in normal control SW1990 cell line and two AMIGO2 siRNA transfected SW1990 cell line; *p < 0.05, **p < 0.01, ***p < 0.001. (C) The mRNA expression of AMIGO2 in normal control MPanc-96 cell line and two AMIGO2 siRNA transfected MPanc-96 cell line; *p < 0.05, **p < 0.01, ***p < 0.001. (D) Relative proliferation tendency in normal control MPanc-96 cell line and two AMIGO2 siRNA transfected MPanc-96 cell line; *p < 0.05, **p < 0.01, ***p < 0.001. (E) The mRNA expression of IL-10, MRC1, CSF1R and TNF-α in untreated and IL-4 treated RAW264.7 cell, *p < 0.05, **p < 0.01, ***p < 0.001. (F) The protein level of AMIGO2 and CSF1R in untreated and IL-4 treated RAW264.7 cell, *p < 0.05, **p < 0.01, ***p < 0.001.